中国脂肪性肝病患病率:基于人群的研究及1740万人的荟萃分析
T-SOLID中SLD患病率为30.8%,其中83.8%为代谢功能障碍相关SLD(MASLD),患病率从2018年22.1%升至2021年36.7%。
要点
- 中国一般人群SLD患病率从2001-2010年23.8%升至2016-2023年27.9%,AAPC=2.56(p<0.0001)。
- T-SOLID中SLD患病率30.8%,其中83.8%为MASLD,2018至2021年从22.1%升至36.7%。
- 东北地区患病率最高(35.0%),男性35.0%高于女性20.6%,患病率随年龄增长从儿童8.1%升至老年人31.8%。
核心结论
- 中国人群SLD患病率普遍上升,凸显针对性的公共卫生干预的迫切需求。
研究设计与样本
- 描述泰州肝脏疾病研究(T-SOLID)中SLD的患病率、亚组分布及临床特征,共28623名参与者。
- 检索五个数据库报告SLD患病率的研究,采用广义线性混合模型分析合格数据,线性回归估计年均百分比变化(AAPC)。
- 荟萃分析纳入792篇文献、17404296名受试者。
主要发现
- T-SOLID中30.8%的参与者诊断为SLD,其中83.8%分类为MASLD;SLD患病率从2018年22.1%升至2021年36.7%。
- 按地区、性别、年龄的亚组及高危人群中均观察到SLD患病率上升;东北地区患病率最高(35.0%)。
- 男性患病率35.0%高于女性20.6%;SLD患病率随年龄增长,从儿童和青少年的8.1%升至老年人的31.8%。
- 荟萃回归识别日历时期、年龄、性别、地理区域和居住区域为SLD患病率的显著决定因素。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Steatotic liver disease (SLD), including metabolic dysfunction-associated SLD (MASLD), has emerged as a leading cause of chronic liver disease in China. AIMS: We aimed to provide a comprehensive and updated description of SLD prevalence in China. METHODS: We described the prevalence, subgroup distribution, and clinical characteristics of SLD in the Taizhou Study of Liver Diseases (T-SOLID). Additionally, we searched for studies reporting SLD prevalence in five databases. Eligible data were analysed using a generalised linear mixed model. Linear regression was applied to estimate the annual average percentage change (AAPC). RESULTS: Of the 28,623 participants in T-SOLID, 30.8% were diagnosed with SLD, among which 83.8% were classified as MASLD. Prevalence of SLD increased from 22.1% in 2018 to 36.7% in 2021. The meta-analysis included 792 publications and 17,404,296 subjects. Nationwide, the pooled SLD prevalence rose from 23.8% (95% CI 21.9%-25.9%) during 2001-2010 to 27.9% (26.0%-29.8%) during 2016-2023 in the general population (AAPC = 2.56, p < 0.0001), equating to approximately 402.0 million cases. An increase in SLD prevalence was observed in subpopulations by region, sex, and age, and in high-risk groups. Northeast China had the highest prevalence (35.0%). Males had a higher prevalence rate than females (35.0% vs. 20.6%). SLD prevalence increased with age, ranging from 8.1% in children and adolescents to 31.8% in the elderly. Meta-regression identified calendar period, age, sex, geographical area, and residence area as significant determinants of SLD prevalence. CONCLUSION: The ubiquitously rising prevalence of SLD in Chinese populations underscores the urgent need for targeted public health interventions.
引用
- Liu Z, Huang J, Dai L, et al. Steatotic Liver Disease Prevalence in China: A Population-Based Study and Meta-Analysis of 17.4 Million Individuals. Aliment Pharmacol Ther. 2025. PMID: 40013739. doi:10.1111/apt.70051
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。